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Abstract 
In order to determine whether tachykinins alter the function of chief cells and to characterize the receptors mediating the effect, we 
investigated the abilities of various substance P (SP)-related peptides to inhibit the binding of 125I-Bolton-Hunter labeled substance P 
(125I-BH-SP) and their abilities to alter cell function in dispersed chief cells from guinea pig stomach. Binding of 125I-BH-SP was 
saturable, reversible, time- anti temperature-dependent and was inhibited by several SP-related peptides with relative potencies of 
SP = physalaemin (IC5o: 0.19 nM) > SP methyl ester (SP-ME) (IC5o: 3.3 nM) > eledoisin (1C5o: 6.1 nM) > neurokinin A (NKA) (ICso: 
65 nM) > neurokinin B (NKB) (1(750:80 nM). Analyses of these binding data demonstrated that chief cells possess a high and low 
affinity class of binding sites. Neither 125I-NKA nor [phenylalanyl-3,4,5-3H]senktide demonstrated saturable binding to chief cells. Acid 
stripping experiments demonstrated rapid ligand internalization with 55% of the bound radioligand internalized by 10 min. Phospholipase 
C activating agents (carbachol, CCK-8), adenylate cyclase activating agents (secretin, VIP), TPA and the calcium ionophore, A23187, all 
inhibited the binding of 12SI-BH-SP and it was due to inhibition of ligand internalization with no change in surface bound parameters. SP 
(0.1 /xM) stimulated pepsinogen secretion but was 4-times less efficacious than CCK-8 (10 nM) or carbachol (1 mM). 10 nM SP 
stimulated a rapid increase in cytoplasmic free calcium concentration ([Ca 2÷ ]i) followed by a sustained elevation lasting 2 min. Single 
cell spectroscopy demonstrated SP (10 pM to 1 /xM) did not cause calcium oscillations. The NK~ receptor antagonist, CP96,345 
specifically inhibited the SP-stimulated changes in [Ca2÷] i and pepsinogen secretion. The relative potencies of SP-related peptides to 
stimulate pepsinogen secretion and [Ca 2+ ]i demonstrated a close agreement with their abilities to inhibit the binding of t2SI-BH-SP, and 
comparison of the dose-response curves suggests occupation of the low affinity sites mediate changes in biologic activity. In conclusion, 
the present study demonstrates that chief cells possess a NK l subtype of tachykinin receptor, occupation of the low affinity sites of this 
receptor cause calcium mobilization and pepsinogen secretion, and that binding to this receptor is regulated by agents that activate 
phospholipase C, adenylate cyclase, protein kinase C and calcium mobilization. 
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1. Introduction 
The putative neurotransmitters, substance P, neurokinin 
A (NKA) and neurokinin B (NKB) belong to a family of 
related peptides, the tachykinins, and possess a wide vari- 
eties of biological activities including sensory transmission 
in the nervous system [1,2], contraction/relaxation f 
smooth muscle [3] as well as stimulation of exocrine gland 
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secretion [4-6]. At least three subtypes of tachykinin 
receptors, NK 1, NK 2 and NK 3 have been established 
whose main endogenous ligands are assumed to be sub- 
stance P, NKA and NKB, respectively [7]. The pharmaco- 
logical classification is based on the relative potency or- 
ders: at the NK 1 receptor, substance P > NKA > NKB: at 
the NK 2 receptor, NKA > NKB > substance P: at the 
NK3 receptor, NKB > NKA > substance P [7]. Recently, 
these three subtypes of receptors have been all cloned and 
found to be members of G protein coupled receptor super- 
family [8-11]. 
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A number of findings uggested that substance P-related 
peptides may be involved in regulation of various gastric 
functions including pepsinogen secretion. First, immuno- 
histochemical studies demonstrated substance P in the 
stomach primarily in neurons in the myenteric and submu- 
cosal plexuses and in sensory neurons with cell bodies in 
the nodose and dorsal root ganglia [12,13]. Second, recep- 
tor autoradiographic studies [14] as well as blot-hybridiza- 
tion studies for mRNA of the receptors [15] revealed that 
the NK 1 and the NK 2 but not the NK 3 subtypes of 
tachykinin receptors are widely distributed in the gastro- 
intestinal tract including the stomach. Finally, substance P 
is reported to stimulate pepsinogen secretion from guinea 
pig dispersed chief cells [16], dispersed rabbit gastric 
glands [17], and from the Atlantic cod stomach [18]. 
However, in these studies the receptors mediating the 
actions of substance P have not been well characterized 
including the receptor subtypes, the exact relationships 
between receptor occupation, changes in intracellular me- 
diator and pepsinogen secretion and whether the receptors 
are regulated by other secretagogues as recently shown in 
pancreatic acini [19,20]. 
The aims of the present study are thus to determine 
which tachykinins directly alter the function of guinea pig 
gastric chief cells, to characterize the receptors mediating 
any effects, to investigate the relationships between recep- 
tor occupation and changes in cell function, and to investi- 
gate the regulation of these receptors by other agents. 
[/3-AlaS]-neurokinin A (4-10) ([fl-Ala8]-NKA (4-10)), 
[MePheT]-neurokinin B ([MePheT]-NKB), CCK-8, car- 
bamylcholine chloride (carbachol), vasoactive intestinal 
peptide (VIP), bombesin, gastrin releasing peptide (GRP) 
and secretin were from Peninsula Laboratories, Belmont, 
CA; 125I-Bolton-Hunter labeled substance P (~25I-BH-SP), 
125I-neurokinin A (125I-NKA) and [phenylalanyl-3,4,5- 
3H]senktide were from New England Nuclear, Boston, 
MA. CP96,345 ((2S,3S)-cys-2-(diphenylmethyl)-N-((2- 
methoxyphenyl)methyl)- 1 -azabicyclo[2.2.2]octan-3-amine) 
was a kind gift from Dr. S.A. Kadin, Pfizer, Groton, CT; 
A71378 (deamino-Tyr(SO 3 H)-Nle-Gry-Trp-Nle-(N- 
methyl)Asp-Phe-NH 2) was a gift from Drs. E.W. Lin and 
A.M. Nadzan, Abbott Laboratories, Abbott Park, IL. 
Unless otherwise stated, the standard incubation solu- 
tion contained the following (in mM): 24.5 Hepes, 98 
NaC1, 6 KC1, 2.5 NaH2PO 4, 5 Na pyruvate, 5 Na fu- 
marate, 5 Na glutamate, 11.5 glucose, 1.5 CaC12, 1.0 
MgC12 and 2 glutamine as well as BSA (0.1% w/v), 
soybean trypsin inhibitor (0.01% w/v), basal amino acid 
medium (1% v/v) and essential vitamin mixture (1% 
v/v). The standard incubation solution was adjusted to pH 
7.4 and equilibrated with 100% 0 2 . All incubation were 
performed at 37°C with 100% 0 2 as the gas phase. 
3. Methods 
3.1. Isolated chief cell preparation 
2. Materials 
Male Hartley guinea pigs (150-300 g) were obtained 
from the Small Animal Section, Veterinary Resources 
Branch, National Institutes of Health. N-2-Hydroxyethyl- 
piperazine-N'-2-ethanesulfonic acid (Hepes) was obtained 
from Boehringer Mannheim Biochemical, Indianapolis, IN; 
collagenase (type I), soybean trypsin inhibitor, bovine 
hemoglobin, polyethylenimine, and ethylene glycol-bis 
(fl-aminoethylester)-N,N'-tetraacetic ac d (EGTA) were 
from Sigma Chemical, St. Louis, MO; Eagle's basal amino 
acid medium (100-times concentrated) was from Gibco, 
Grand Island, NY; essential vitamin mixture (100-times 
concentrated) was from Microbiological Associates, 
Bethesda, MD; glutamine was from Research Plus Labora- 
tories, Bayonne, NJ; bovine serum albumin (fraction V) 
(BSA) was from Miles Laboratories, Elkhart, IN; Percoll 
was from Pharmacia, Piscataway, NJ; fura-2 acetoxy- 
methyl ester (fura-2/AM) was from Molecular Probes, 
Eugene, OR; Cell-Tak was from Becton Dickinson Lab- 
ware, Bedford, MA; phosphoramidon, A23187 and 12-0- 
tetra-decanoylphorbol-13-acetate (TPA) were from Cal- 
biochem, San Diego, CA; substance P, physalaemin, eu- 
rokinin A (NKA), the methyl ester of substance P (SP-ME), 
the free acid of substance P (SP-OH) were from Bachem, 
Torrance, CA; Neurokinin B (NKB), eledoisin, senktide, 
Dispersed chief cells (> 90% pure) from guinea pig 
gastric mucosa were prepared as described previously [21]. 
Briefly, the minced gastric mucosa was incubated with 
0.2% (w/v) collagenase in standard incubation solution 
without calcium and magnesium for 30 min at 37°C. At 30 
min the glands were strained through a 210 /zm Teflon 
mesh, centrifuged, washed twice and incubated with 2 mM 
EGTA in standard incubation solution without calcium and 
magnesium for 15 min at 37°C. The cells were then 
dispersed by passage three times through a 19-gauge nee- 
dle. After filtering through a 70-/xm nylon mesh and 
centrifuging at 800 × g for 1 min, the pellet was washed 
three times. Purified chief cells (> 90% pure) were pre- 
pared using a Percoll gradient (density, 1.017-1.097) with 
centrifugation at 30000 × g for 15 min at 4°C in a Sorvall 
RC-5B centrifuge (DuPont Instruments). 
3.2. Binding study 
Unless specified otherwise, dispersed gastric chief cells 
(3 X 10 6 cells/ml) were incubated with 70 pM 125I-BH-SP 
for 45 min at 37°C alone or with the indicated concentra- 
tions of unlabeled ligands in standard incubation solution 
containing 1 /zM phosphoramidon. The termination of the 
incubation and the separation of bound from free radioli- 
gand were obtained by centrifugation f the cells through 
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4% (w/v)  BSA in standard incubation solution in mi- 
crofuge tubes using a Beckman Microfuge B. Then the 
tubes were washed twice with 4% (w/v)  BSA in standard 
incubation solution and assayed for radioactivity using a 
auto-gamma scintillation spectrometer (Packard Instrument 
Co., Downers Grove, IL). All binding data in this paper 
unless otherwise specified represent saturable binding, i.e., 
binding measured with ~25I-BH-SP alone (total binding) 
minus binding measured in the presence of 1 /zM sub- 
stance P (nonsaturable binding). In all experiments, non- 
saturable binding was < 20% of total binding. Dose-in- 
hibition curves were analyzed by using a nonlinear least- 
squares curve-fitting program (LIGAND) [22]. 
Dissociation was perforrned by diluting samples 100- 
fold in incubation buffer and then filtering the samples at 
various times using Whatman GF/C  filters (soaked in 
0.3% polyethylenimine overnight). 
For acid-stripping experiments, after incubation with 
cells as described above for the indicated periods of time, 
100 /zl of cell suspensions were treated with 1 ml of acid 
wash solution (0.2 M acetic acid in 0.5 M NaC1) for 5 min 
at 4°C as described by Haigler et al. [23]. The saturable 
binding remaining after acid-stripping was defined as inter- 
nalized ligand and the saturable binding removed by the 
acid wash was defined as the surface bound ligand. 
Degradation of the radioligand uring incubation was 
determined by measuring the decrease of trichloroacetic 
acid-precipitable radioactivity in the supernatant of the 
incubation mixture [24]. Specifically, 125I-BH-SP was in- 
cubated with cells as described above, 100 /zl of super- 
natant was placed in 0.5 ml of trichloroacetic acid (200 
mg/ml) and 0.4 ml of standard incubation solution was 
added to provide carrier protein. After remaining at 4°C for 
15 min, the sample was centrifuged at 3000 X g for 10 
min at 4°C and the radioactivity of the pellet was measured 
and expressed as a percentage of the total radioactivity. 
~25I-BH-SP processed under identical conditions not ex- 
posed to cells was 86.5 + 3.2% acid precipitable. 
3.3. Measurement ofpepsinogen secretion 
Pepsinogen secretion was measured using a slight modi- 
fication of the method described previously [21,25,26]. 
Briefly, dispersed chief cells (1.2 × 105 cells/ml) were 
incubated alone or with the secretagogues at 37°C for 1 
rain. Pepsinogen activity released into the extracellular 
medium was measured using ~25I-hemoglobin. Pepsinogen 
secretion was expressed as percent otal secreted, i.e., the 
percentage of the total pepsinogen in the cells at the 
beginning of the incubation that was released into the 
extracellular medium during the incubation. 
3.4. Measurement of cytoplasmic-free calcium ([Ca 2 + ]i) 
Changes in [Ca2+] i in gastric chief cells were per- 
formed as described recently [27]. Briefly, dispersed chief 
cells (1-2 × 106 cells/ml) were suspended in standard 
incubation solution and incubated with 1 ~M fura-2/AM 
for 30 min at 37°C. Fura-2-1oaded cells were then washed 
three times and resuspended in standard incubation solu- 
tion at 4°C. The fluorescence of fura-2-1oaded chief cells 
was measured using a Delta PTI Scan 1 Spectrofluorimeter 
(PTI Instruments, Gaithersburg, MD) that had provision 
for maintaining the incubation temperature at 37°C and for 
mixing the cell suspension with a magnetic stirrer in the 
fluorimeter cuvette. 
Determination of changes in [Ca2+] i in a single cell 
were determined as described previously [28]. Briefly, 
aliquots (400 /zl) of cell suspension (1 X 105 cells/ml in 
BSA free standard incubation solution) were centrifuged 
(1000 X g for 1 min) in glass sample chambers precoated 
with Cell-Tak (3.5 g /cm 2 surface area). Adherent cells 
were incubated at room temperature for at least 30 min 
with standard incubation solution containing 2 /zM fura- 
2/AM. After removing extracellular fura-2/AM by wash- 
ing with standard incubation solution, sample chambers at 
room temperature were placed on the stage of Nikon 
Diaphot microscope coupled to an ARCM-MIC microfluo- 
rimeter (Spex Industries, Edison, NJ). Fura-2 fluorescence 
from single cell (isolated by a pinhole aperture) was 
monitored by alternate (60 Hz) excitation at 340 nm and 
360 nm and emission at 500 nm as described previously 
[28]. 
[ Ca2 + ]i was calculated by the method of Grynkiewicz et 
al., [29] using the formula: [Ca2+] i = K d × (R -  
Rmin)/(Rma x -R )X  Sf /Sb,  where K d is the affinity of 
fura-2 for Ca 2+ (determined to be 224 nM), R is 
F340///~360, i.e., the ratio of the fluorescence with the two 
excitation wavelengths, Rma x is the F340//F360 ratio in a 
saturated Ca 2÷ environment after addition of 0.1% Triton- 
X, Rmi n is the fluorescence ratio at virtually zero calcium 
(addition of 25 mM EGTA), Sf is the F360 at zero Ca 2÷ 
and S b is the F360 at saturated Ca 2+. 
3.5. Protein determination 
Protein content was determined by the use of the Bio- 
Rad protein assay reagent with bovine albumin as a stan- 
dard. 
3.6. Data analyses 
Results were expressed as mean + SEM. Statistical sig- 
nificance of difference between means was determined 
using Student's t-test (potentiation studies, binding stud- 
ies) and a two-way analysis of variance (time-course of 
pepsinogen release). Differences were considered to be 
significant if the P value was < 0.05. ECso, the agonist 
concentration causing half-maximal stimulation, and IC5o, 
the antagonist concentration causing half-maximal inhibi- 
tion, were calculated using the curve-fitting program 
Kaleidograph. 
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4. Results 
Binding of I:5I-BH-SP to gastric chief cells was time- 
and temperature-dependent (Fig. 1). At 37°C binding 
reached maximal at 45 min and remained constant for an 
additional 75 min. At 22°C binding reached maximal at 60 
to 90 min and remained constant for an additional 30 min. 
More radioligand was bound at 22°C than at 37°C between 
60 and 120 min. At 4°C, binding was reduced and reached 
only 33% of that seen at 22°C by 120 min. The addition of 
1 /zM substance P reduced binding at 37°C by 90%, at 
22°C by 90%, and at 4°C by 60% at 120 min incubation 
(Fig. 1). To determine whether degradation of the radioli- 
gand could be occurring at 37°C, the degree of radioligand 
degradation was assessed by the trichloroacetic acid pre- 
cipitation method. The degree of radioligand degradation 
during a 45-min incubation was 0 ___ 3% at 4°C, 3 __+ 4% at 
22°C and 7 _+ 3% at 37°C and during a 90-min incubation 
was 1_+5% at 4°C, 15+4% at 22°C and 26_5% at 
37°C. Binding reached equilibrium by 45-60 min (Fig. 1), 
thus there was minimal degradation over this time period. 
To determine the kinetics of binding further, the re- 
versibility of binding of ~25I-BH-SP to chief cells were 
investigated (Fig. 2). After binding for 60 min at 37°C and 
then diluting the cells 100-fold with or without 1 /zM 
substance P present, the dissociation of ~25I-BH-SP at 37°C 
was assessed. Dissociated emonstrated a two-component 
process. Under both conditions the initial component of 
dissociation was rapid, occurring over the first 15 min. The 
second component slowly dissociated over the next 45 min 
(Fig. 2, inset). Because of the rapid dissociation followed 
by a slower incomplete component of dissociation, the 
possibility that some of the radiolabeled ligand might be 
internalized, was considered. 
Binding of ~25I-BH-SP was inhibited in a dose-depen- 
dent fashion by substance P and various substance P-re- 
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Fig. 1. Time and temperature dependence of binding of J25I-BH-SP to 
gastric chief cells. Cells (3 × l06 cells/ml) were incubated with 70 pM 
~25I-BH-SP for up to 120 min at 4°C, 22°C or 37°C, alone or plus 1 /~M 
substance P. Radioactivity bound to cells at the time indicated was 
determined as described in Methods and expressed as percentage of total 
added radioactivity. Each value was determined in duplicate and results 
are mean-I-SEM from 3 separate xperiments. 
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Fig. 2. Time-dependence of the dissociation of ~2SI-BH-SP from gastric 
chief cells. Cells (3× 10 6 cells/ml) were first incubated with 70 pM 
]251-BH-SP for 60 min at 37°C. At that ime, cells were diluted 100-fold 
into standard incubation solution at 37°C alone or with 1 /xM substance P 
and were incubated for the indicated times. Radioactivity bound to cells 
was determined byfiltration and expressed aspercentage of the saturable 
binding at the beginning of second incubation. Each value was deter- 
mined in duplicate and results are mean-J-SEM from 3 separate experi- 
ments. Inset shows the amount of saturable binding at any time, B t 
plotted as a natural logarithm function of the amount of saturable binding 
present at zero time, B 0. 
luted peptides (Fig. 3, Table 1). Substance P and 
physalaemin were the most potent with a detectable inhibi- 
tion at 0.01 nM, half-maximal inhibition (ICso) at 0.19 nM 
and complete inhibition at 10 nM. The methyl ester of 
substance P (SP-ME) ( IC50:3.3 nM) was 17-times less 
potent han substance P, whereas eledoisin (IC50:6.1 nM) 
was 32-times less potent; NKA ( IC50:65 nM) was 340- 
times less potent and NKB (1(750:80 nM) was 420-times 
less potent than substance P (Table 1). The free acid of 
substance P (SP-OH), the selective NK 2 receptor agonist, 
[ f l-AIas]-NKA(4-10) and the selective NK 3 receptor ago- 
nists, senktide and [MePhe7]-NKB, had low potency for 
inhibiting binding of 125I-BH-substance P (Fig. 3, Table 1). 
The selective NK 1 receptor antagonist, CP96,345 (IC5o: 
0.28 nM) demonstrated qual potency to substance P (Fig. 
3, Table 1). When the results of inhibition of binding of 
]25I-BH-SP by substance P were analyzed using a nonlin- 
ear least-squares curve-fitting program LIGAND [22], the 
data was better fit by a two binding site model compared 
to a single site model (P  = 0.007). One site had a high 
affinity for substance P (K d 0.045+0.011 nM), low 
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Fig. 3. Abilities of various neurokinin-receptor agonists and antagonists 
to inhibit binding of 125I-BH-SP to gastric chief cells. Cells (3x  106 
cells/ml) were incubated with 70 pM 125I-BH-SP for 45 min at 37°C 
alone or plus the agent indicated. Radioactivity bound to cells was 
determined as described in Methods and expressed as percentage of the 
saturable binding with no unlabeled peptide added (i.e., % control). Each 
value was determined in duplicate and results are means-t-SEM from 3 
separate experiments. Abbreviations: NKA = neurokinin A; NKB = 
neurokinin B; SP-ME = methyl ester of substance P; SP-OH = free acid 
of substance P; [ fl-AlaS]-NKA (4-10) = [ fl-AlaS]-neurokinin A (4-10); 
[MePhe 7]-NKB = [MePhe 7 ]-neurokinin B. CP96,345 is an NK l receptor 
antagonist whose structure is listed in Section 2. 
binding capacity of 41 ___ 5 fmol/mg protein or 1930 + 235 
sites/chief cells and the other binding site had a low 
affinity (K d 21 _+ 10 nM), but high capacity of 719 -4- 356 
fmol/mg protein or 34000_+ 17000 sites/cell. The 
physalaemin, SP-ME, eledoisin and NKA dose-inhibition 
curves (Fig. 3) when similarly analyzed using the curve-fit- 
ting program, LIGAND [22], had high affinity sites of 
0.046 nM, 0.77 nM, 2.1 nM and 15 nM, respectively, and 
low affinity sites of 24 nM, 430 nM, 360 nM and 1000 
nM, respectively. To determine whether additional 
tachykinin receptor subtypes existed on gastric chief cells, 
we also performed binding study using the relatively selec- 
tive NK 2 receptor adioligand; 125I-NKA [30] and selec- 
tive NK 3 receptor radioligand; [phenylalanyl-3,4,5- 
3H]senktide [31]. Neither mSI-NKA nor [phenylalanyl- 
3,4,5-3H]senktide demonstrated saturable binding to gas- 
tric chief cells (data not shown). 
To examine the specificity of the binding of 125I-BH-SP 
to gastric chief cells, various peptides unrelated to 
tachykinins that were reported to interact with chief cells 
were tested for their abilities to inhibit binding of 125I-BH- 
SP (Table 2). CCK-8 (1 /xM), the CCK A receptor selec- 
tive agonist A71378 (1 /xM), carbachol (1 mM), secretin 
(1 /xM), VIP (1 /xM), 8-Br-cAMP (1 mM), TPA (0.01 
/xM) and the calcium ionophore, A23187 (0.3 /xM), all 
inhibited binding of ~25I-BH-SP. In contrast, gastrin (1 
/xM), bombesin (1 /xM) or GRP (1 /xM) did not signifi- 
cantly inhibit the binding: of ~25I-BH-SP (Table 2). The 
Table 1 
Abilities of tachykinin receptor agonists and antagonists o inhibit binding 
of t25I-BH-SP and to stimulate or inhibit substance P-stimulated changes 
in [Ca 2+ ]i and pepsinogen secretion 
Agent ~25I-BH-SP Changes in Pepsinogen 
binding [ Ca2+ ]i secretion 
1C50 (nM) ECso (nM) ECso / K i (nM) 
Agonist: ECso: 
Substance P 0.19 + .02 2.0 5:0.7 0.77 4- 0.35 
Physalaemin 0.19+0.06 0.83+0.26 0.574-0.01 
SP-ME 3.3+0.88 11.44-4.6 1.344-0.34 
Eledoisin 6.1 +0.48 12.44-3.5 3.9+ 1.6 
NKA 654-20 1034-25 142+27 
NKB 804-50 260+98 185+36 
Senktide > 1000 > 1000 > 1000 
SP-OH 2800+300 > 1000 > 1000 
[ fl-AlaS]-NKA (4-10) > 1000 > 1000 > 1000 
[MePhe7 ]-NKB > 1000 > 1000 > 1000 
Antagonist: Ki: 
CP96,345 0.28 4- .03 ND 0.58 4- 0.22 
Values represent means+SEM from at least 3 separate xperiments. 
Values of IC5o were calculated by analyzing the data in Fig. 3 using the 
curve-fitting program Kaleidograph and the K i was calculated using a 
nonlinear least-squares curve-fitting program (LIGAND) [22]. Values of 
ECs0, the concentration that causes half-maximal stimulation of changes 
in [Ca 2÷ ]i and pepsinogen secretion, were calculated from the data in 
Figs. 7 and 9 as described in Section 3. To calculate the K i for 
pepsinogen release for CP96,345, pepsinogen release was determined 
using increasing concentrations of substance P with and without 1 nM 
CP96,345 present. Values of K i were calculated by using the Schild 
equation: log K i = log H- log  (DR-l) where DR is the observed ose 
ratio, i.e., the concentration of substance P required to give half-maximal 
stimulation of pepsinogen secretion in the presence of antagonist to the 
concentration required in the absence of antagonist; H is the concentra- 
tion of antagonist. Abbreviations: ame as for Fig. 3. 
ND = not determined. 
Table 2 
Effects of various agents on binding of t25I-BH-SP to gastric chief cells 
Agent added (/zM) uSI-BH-SP bound 
(% control) 
Substance P (0.001) 13 + 1 * 
CCK-8 (1) 864- 2 * 
A71378 (1) 874-1 * 
Gastrin (1) 1044-2 
Carbachol (1000) 91 4- 2 * 
Bombesin (1) 107 4- 8 
GRP (1) 1044-4 
Secretin (1) 815:1 * 
VIP (1) 864-4 * 
CCK-8 (1) plus Secretin ( 1 ) 73 + 2 * 
8 Br-cAMP (1000) 80+4 * 
TPA (0.01) 81 +6 * 
A23187 (0.3) 724-3 * 
TPA (0.01) plus A23187 (0.3) 51 4-2 * 
* Significantly (P  < 0.05) different compared to control. Cells (3)< 106 
cells/ml) were incubated with 70 pM 125I-BH-SP plus the indicated 
agents for 45 min at 37°C. Radioactivity bound to cells was determined as 
described in Section 3 and expressed as a percentage of the saturable 
binding with no unlabeled peptide added (i.e., % control). Each value was 
determined in duplicate and results are mean +SEM from 3 separate 
experiments. 
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Fig. 4. Abilities of the phorbol ester TPA alone or in combination with 
the calcium ionophore, A23187, to inhibit binding of t25I-BH-SP to 
gastric chief cells. Cells (3 × 106 cells/ml) were incubated with 70 pM 
I251-BH-SP for 45 rain at 37°C alone or plus the agent indicated. 
Radioactivity bound to cells was determined as described in Methods and 
expressed as percentage of the saturable binding with no agent added 
(i.e., % control). Each value was determined in duplicate and results are 
mean + SEM from 3 separate xperiments. 
combination of CCK-8 and secretin demonstrated signifi- 
cantly greater inhibition than that seen with either agent 
alone (Table 2). Inhibition of binding of 125I-BH-SP with 
TPA was dose-dependent wi h detectable inhibition at 0.1 
nM, IC5o at 2.0 nM and maximal inhibition at 100 nM 
(Fig. 4). The combination of the phorbol ester TPA, and 
the calcium ionophore A23187 (0.3 /xM), demonstrated 
significantly greater inhibition than that seen with either 
agent alone, however, did not demonstrate potentiation 
(Fig. 4 and Table 2). Preincubation for 15 min with the 
various secretagogues in Table 2 did not increase the 
magnitude of their effects on 125I-BH-substance P binding. 
To determine whether the inhibitory effect of these 
agents on binding of 125I-BH-SP occurred by altering 
internalization of the ligand or by altering surface bound 
ligand and to investigate the possibility that the incom- 
pleteness and slowness of dissociation shown in Fig. 2 
might be due to internalization f the ligand, acid-stripping 
experiments were performed (Fig. 5). The ligand internal- 
ization was rapid with 55% of the bound radioligand was 
already internalized at 10 min incubation. Maximal inter- 
nalization was achieved by 30 min with 60% of bound 
radioligand being internalized (Fig. 5). TPA (0.01 /zM) 
significantly inhibited the ligand internalization between 
30 and 60 min incubation, whereas it did not cause a 
significant effect on the surface bound ligand binding (Fig. 
5). Similar to TPA, CCK-8 (1 tzM), secretin (1 /~M), 
A23187 (0.3 /zM) and the combination of CCK-8 and 
secretin all significantly inhibited the ligand internaliza- 
tion, whereas these agents demonstrated minimal effect on 
surface bound ligand binding (Table 3). In contrast, the 
combination of TPA and A23187 significantly reduced the 
amount of both surface bound ligand and internalized 
ligand (Table 3). 
In some cells such as pancreatic acinar cells [19], the 
binding of 12SI-BH-SP is markedly effected by the concen- 
tration of extracellular calcium. To determine whether this 
is also true in gastric chief cells, the effect of the concen- 
tration of extraceilular calcium on surface bound or inter- 
nalized 125I-BH-SP was determined ( ata not shown). With 
0 mM calcium and 1.0 mM EGTA, after a 60-min incuba- 
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Fig. 5. Effect of the phorbol ester, TPA, on the internalization of 125I-BH-SP at different imes. Cells (3 × 106 cells/ml) were incubated with 70 pM 
~25I-BH-SP alone or plus 0.01 /zM TPA for the indicated periods of time at 37°C. Surface bound ligand was that proportion of the saturably bound 
radioactivity removed by exposure to 0.2 M acetic acid with 0.5 M NaC1 (pH 2.5), as described in Section 2, whereas the internalized ligand was the 
proportion ot removed. Results are expressed as the amount of saturably bound t25I-BH-SP that was bound at each time that was either surface bound 
(left panel) or internalized (right panel). Each value was determined in duplicate and results are mean _+ SEM from 3 separate xperiments. 
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Table 3 
Effects of various agents on the surface binding and internalization of 
125I-BH-SP in gastric chief cells 
Agent added (/xM) 12 s I-BH-SP bound ( fmol /mg protein) 
Surface bound Internalized 
None 6.0 4- 1.0 7.94- 1.4 
CCK-8 (1) 5.8+ 1.0 5.64-0.8 * 
Secretin (1) 6.6 + 0.8 5.3 + 0.9 * 
CCK-8 (1) plus Secretin (1) 5.5 4- 1.1 5.04-0.7 * 
TPA (0.01) 6.7 + 0.7 5.6 4- 1.0 * 
A23187 (0.3) 5.3 + 0.9 5.7 4- 0.9 * 
TPA (0.01) plus A23187 (0.3) 3.34-0.3 * 3.94-0.4 * 
* Significantly (P  <0.05) different compared to no additions. Cells 
(3X 106 cells/ml) were incubated with 70 pM 125I-BH-SP plus the 
indicated agents for 30 min at 37°C. Surface bound ligand was that 
proportion of the saturably bound counts removed by exposure to 0.2 M 
acetic acid with 0.5 M NaC1 (pH 2.5), as described in Section 3. The 
internalized ligand was the proportion not removed by acid-stripping. 
Results are expressed as the amount of saturably bound 125I-BH-SP that 
was either surface bound or internalized. Each value was determined in 
duplicate and results are means 4- SEM from 3 separate xperiments. 
tion at 37°C surface binding of 12SI-BH-SP was 6.2 4- 0.9 
fmol/mg protein and 7.5 ___ 1.1 fmoi/mg protein was 
internalized. With 0.25 mM or 1.5 mM extracellular cal- 
cium the amount of t25I-BH-SP bound on the surface or 
internalized was not significantly different from the values 
with no calcium present. 
To investigate the abilities of substance P-related pep- 
tides to alter cell function, we first examined the ability of 
substance P to stimulate pepsinogen secretion (Fig. 6). 
Substance P (1 /zM) caused a doubling of pepsinogen 
release, with the maximal rate of stimulation in < 1 min, 
and then the rate of secretion was similar to control (Fig. 
6). Therefore, all pepsinogen release studies were done at 
an incubation time of 1 rnin. A maximally effective con- 
centration of substance P (0.1 /xM) caused the release of 
1.5 4- 0.3% of the total cellular pepsinogen during 1 min 
incubation (Table 4) and was 3.5-times and 3.4-times less 
efficacious than carbachol (1 mM) or CCK-8 (10 riM), 
respectively, but similar to the increase caused by VIP (1 
/xM) or secretin (10 nM) in 1 min (Table 4). Among the 
naturally occurring tachykinins, physalaemin and sub- 
stance P were the most potent in stimulating pepsinogen 
secretion with detectable stimulation at 0.1 nM, half-maxi- 
mal stimulation (ECs0) at 0.6-0.8 nM and maximal stimu- 
lation at 10 nM (Fig. 7, Table 1). The relative potencies of 
other tachykinin receptor agonists were as follows, 
physalaemin = substance P > SP-ME (ECs0; 1.3 nM)> 
eledoisin (ECso; 3.9 nM) > NKA (ECso; 142 nM)= NKB 
(ECs0; 185 nM). Up to t /zM concentrations of SP-OH, 
[/3-AIaS]-NKA(4 - 10), senktide and [MePhe 7]-NKB only 
caused 40% of the maximal secretion caused by substance 
P (Fig. 7). These relative potencies of the peptides to 
stimulate pepsinogen secretion demonstrated a close agree- 
ment with those to inhibit the binding of ~2SI-BH-SP. 
CP96,345 has been described as a specific NK~ receptor 
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Fig. 6. Time course of pepsinogen release stimulated by substance P from 
dispersed gastric chief cells. Dispersed chief cells (1.2X 105 cells/ml) 
were incubated at 37°C with or without substance P (1 /zM) for the times 
indicated. Pepsinogen activity release into the extracellular medium was 
determined as described in Methods. Each value was determined in 
duplicate and results were mean-I-SEM from 3 separate xperiments. 
Pepsinogen release from chief cells with substance P present was signifi- 
cantly greater (P  < 0.02) than chief cells without substance P present 
(i.e., alone) at all time points except 0 time. 
antagonist [32]. At 1 /~M, CP96,345 completely inhibited 
1 nM substance P-simulated pepsinogen secretion, how- 
ever, had no effect on stimulation caused by CCK-8 (1 
nM), carbachol (10 /zM), VIP (1 /zM), or secretin (10 
Table 4 
Effects of a maximal concentration of various secretagogues on stimula- 
tion of pepsinogen secretion from gastric chief cells 
Agent added Stimulated pepsinogen 
secretion (% total) 
None 2.62 4- 0.39 
Carbachol (10/~M) 8.27 4-0.65 
CCK-8 (1 nM) 7.874- 1.09 
VIP (1 /xM) 4.25 4-0.20 
Secretin (10 nM) 4.24 4- 0.34 
Substance P (1 p,M) 4.104-0.39 
Cells (1.2 x 105 cells/ml) were incubated at 37°C for 1 min. Pepsinogen 
activity released into the extracellular medium was determined as de- 
scribed in Section 3. Results are expressed as the percentage of the 
pepsinogen activity in the chief cells at the beginning of the incubation 
that was released into the extracellular medium during the incubation. 
Each value was determined in duplicate and results are mean 4- SEM from 
3 separate xperiments. 
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Fig. 7. Abilities of various substance P-related peptides to stimulate 
pepsinogen secretion from gastric chief cells. Cells (1.2 X 105 cells/ml) 
were incubated at 37°C for 1 min. Pepsinogen activity released into 
extracellular medium was determined as described in Methods. Results 
are expressed as the percentage of stimulation caused by 1 /xM substance 
P. The basal and substance P (1 /xM) stimulated values were 1.2+0.2 
and 2.8-t-0.2% of the total cellular pepsinogen, respectively. Each value 
was determined in duplicate and results are mean + SEM from 3 separate 
experiments. Abbreviations: ame as the legend of Fig. 3. 
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Fig. 8. Effect of substance P and carbachol on [Ca 2+ ]i (upper panel) and 
inhibitory effects of the NK I receptor antagonist, CP96,345, on stimu- 
lated changes in [Ca 2+ ]i by these agonists (lower panel) in single 
optically isolated chief cell. Changes in [Ca 2+ ]i in a single cell were 
determined using fura-2 and microspectrofluorimetry as described in 
Section 2. These experiments are representatives of at least three other 
experiments. 
nM) (data not shown). To determine the affinity of 
CP96,345 for the NK~ receptor, a fixed concentration (i.e., 
1 nM) of CP96,345 was incubated with increasing concen- 
trations of substance P. Using the Schild equation the 
affinity of CP96,345 for inhibiting substance P-stimulated 
pepsinogen release was similar to the ECso of substance P 
(Table 1). 
To determine whether substance P caused potentiation 
of stimulation of pepsinogen release by other secreta- 
gogues, a maximally effective dose of substance P (1 /zM) 
was incubated with other secretagogues (Table 5). Sub- 
stance P caused significantly greater stimulation with se- 
cretin than the expected additive value (P < 0.05), whereas 
it did not with CCK-8 present (Table 5). These data 
suggest hat substance P and CCK-8 may have a similar 
cellular basis of action. 
Table 5 
Effect of substance P on stimulation of pepsinogen release by various 
secretagogues 
Agent added Stimulated pepsinogen secretion (% total) 
Alone Plus substance P (1 /~M) 
none 0.85:0.1 2.1 +0.3 
CCK-8 (0.1 /xM) 7.3 5z 1.5 7.0 5:1.5 (9.4) 
secretin (0.1 /xM) 2.95:0.9 5.55-1.2 (4.2) * 
" Significantly (P  < 0.05) less than the observed value. 
Chief cells (1.2X 105 cells/ml) were incubated for 1 min alone, with 
CCK-8 or secretin, with or without substance P (1 /xM). Results are 
expressed as the percentage of the total cellular pepsinogen released 
during incubation. Values are means from 3 experiments. Values in 
parentheses represent the expected additive value. 
To gain more insight into the effect of activation of 
tachykinin receptors on cellular function in gastric chief 
cells, we investigated their abilities to change cytoplasmic 
free calcium ([Ca2+]i) (Figs. 8 and 9). In single cells, 10 
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Fig. 9. Abilities of various tachykinin receptor agonists to stimulate 
changes in [Ca 2+ ]i of gastric hief cells. Cells ( I -2  × 106 cells/ml) were 
loaded with 1 /xM fura-2/AM for 30 min at 37°C. Changes in [Ca 2+ ]i of 
a cell suspension were determined as described in Methods in a cuvette 
using a PTI spectrofluorimeter. Results are expressed as the maximal 
increase in [Ca 2+ ]i stimulated by substance P (1 /~M). The basal and 1 
/zM substance P stimulated [Ca 2+ ]i were 93+4 and 134-1-3 nM. Each 
value was determined in duplicate and results are mean + SEM from 3 
separate xperiments. Abbreviations: ame as in Fig. 3. 
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nM substance P stimulated a rapid increase in [Ca2+] i to 
the same level stimulated by 10 /xM carbachol followed 
by a sustained elevation of [Ca 2÷ ]i lasting 2 min (Fig. 8, 
upper panel). No single cell demonstrated calcium oscilla- 
tions by the addition of substance P using concentrations 
from 10 pM to 1 /xM, however, calcium oscillations were 
seen with low concentrations of CCK-8 (data not shown). 
Addition of the NK 1 receptor antagonist, CP96,345 (1 
/zM), completely inhibited 10 nM substance P-stimulated 
changes in [Ca 2÷ ]i in every cell tested, however had no 
effect on carbachol-stimulated changes in [Ca 2÷ ]i (Fig. 8, 
lower panel). To determine the dose-response relationships 
of several substance P-related peptides, we measured 
changes in [Ca2+]i in fluorimeter cuvette containing 1-2 
X 106 cells (Fig. 9). Maximally effective concentrations of 
substance P (1 /zM) caused a rapid increase in [Ca 2+ ]i of 
41 + 4 nM over the basal level of 100 nM, which was 
4-times less efficacious than that seen with maximally 
effective concentration of carbachol which increased 
[Ca2+]i 179+ 12 nM over the basal value. For the 
tachykinin receptor agonists, physalaemin and substance P 
were the most potent in stimulating increase in [Ca2+] i 
with detectable stimulation at 0.1 nM, half-maximal stimu- 
lation (ECs0) at 1-2 nM and maximal stimulation at 10 
nM (Fig. 9). The relative potencies of other tachykinin 
receptor agonists were as follows, physalaemin = substance 
P > SP-ME (ECs0; 11.4 nM)= eledoisin (ECs0; 12.4 nM) 
> NKA (ECso; 103 nM)= NKB (ECs0; 260 nM) (Table 
1). Up to 1 /xM concentrations of SP-OH, [/3-AlaS] -
NKA(4-10), senktide and [MePhe 7]-NKB did not stimu- 
late increase in [Ca 2+ ]i (Table 1). The relative potencies of 
these peptide to stimulate increase in [Ca 2+ ]i demonstrated 
a close agreement with those to inhibit the binding of 
125I-BH-SP and with those to stimulate pepsinogen secre- 
tion (compare Figs. 3 and 7, Fig. 9) (Table 1). 
5. Discussion 
In the present study a number of results demonstrate 
that guinea pig gastric chief cells possess a high affinity 
receptor for substance P-related peptides that is of the NK 1 
subtype and occupation of these receptors results in 
pepsinogen secretion. Substance P and related tachykinins 
stimulate pepsinogen secretion and alter [Ca 2÷ ]i in chief 
cells. Radiolabeled substance P bound to chief cells and 
the binding was saturable, reversible and time- and temper- 
ature-dependent which are characteristic for receptor bind- 
ing [5,33]. The evidence that the receptor has high affinity 
is that radiolabeled substance P binding is inhibited half- 
maximally in the nanomolar range by substance P. The 
fact that the receptor is ,an NK 1 subtype is supported by a 
number of results. First, the binding of radiolabeled sub- 
stance P was inhibited by several substance P-related 
peptides and their absolute and relative potencies for inhi- 
bition of the binding of radiolabeled substance P to gastric 
chief cells agreed closely with the values obtained in the 
cloned substance P receptor (NK 1 receptor) from rat brain 
expressed in COS cells [8]. Second, neither the relatively 
selective radioligand for NK 2 receptors, 125I-NKA nor the 
selective radioligand for NK 3 receptors, [phenylalanyl- 
3,4,5-3H]senktide monstrated specific binding to chief 
cells. Third, neither the selective NK 2 receptor agonist, 
[/3-AlaS]-NKA(4-10) nor the selective NK 3 receptor ago- 
nists, senktide and [MePheT]-NKB demonstrated high 
affinity inhibition of binding of radiolabeled substance P to 
gastric chief cells or stimulation of pepsinogen secretion. 
Finally the selective NK~ receptor antagonist CP96,345 
demonstrated high affinity inhibition of binding of radiola- 
beled substance P.
The NK~ receptors in gastric chief cells have both 
similarities and differences with NK~ receptors in other 
tissues. In the present study, the NK~ receptor had a high 
affinity for substance P (IC5o = 0.2 nM) and 320-fold and 
420-fold lower affinity for NKA and NKB, respectively. 
The absolute affinity of the NKI receptor in chief cells for 
substance P agrees closely with the value obtained from 
the binding study in canine chief cells [34], rat brain [35], 
dog kidney [36], or the rat pancreatic acinar tumor cell 
line, AR4-2J cells [37], however it is 40-times higher than 
the value obtained from rat parotid cells [38]. Our study 
demonstrated that the NK~ receptor on gastric chief cells 
has a high and low affinity binding site with K d values of 
0.045 nM and 21 nM and binding capacities of 41 fmol/mg 
protein or 1930 sites/cell and 719 fmol/mg protein or 
34000 sites/cell, respectively. The high affinity receptor 
capacity is similar to the reported capacity of 3000 
sites/cell in canine gastric chief cells [34], 49 fmol/mg 
protein in rat parotid acinar cells [38] or 2300 sites/cell in 
guinea pig pancreatic acini in one study [19]; however, it is 
3-fold larger in number than 500 sites/cell in another 
study in guinea pig pancreatic acini [6] and is 6-fold 
smaller in number than 11 000 sites/cell in AR4-2J cells 
[37]. The finding that the binding to the NK~ receptor is 
better fitted by a two binding site model than a one site 
model is in agreement with some [5,37,39,40] but not other 
[5,6,41] studies of NK 1 receptors in different tissues. 
A number of results support the conclusion that the 
occupation of NK 1 receptors identified by the binding 
studies in gastric chief cells are the receptors responsible 
for mobilization of cellular calcium and stimulation of 
pepsinogen secretion by substance P-related peptides. First, 
the relative potencies of tachykinin receptor agonists for 
inhibition of radiolabeled substance P showed a close 
agreement with their relative abilities to stimulate changes 
in [Ca 2+ ]i and pepsinogen secretion. Specifically, in each 
case the relative potencies were substance P = 
physalaemin > SP-ME > eledoisin > NKA > NKB. Sec- 
ond, the NK 1 receptor selective antagonist CP96,345 
specifically inhibited the substance P-stimulated changes 
in [Ca 2÷ ]i and pepsinogen secretion and the calculated K i 
value to inhibit substance P-stimulated pepsinogen secre- 
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tion (1 nM) was in fairly good agreement with the calcu- 
lated K d value for CP96,345 (0.3 nM) from the binding 
studies. Third, similar to the binding studies, the selective 
NK 2 receptor agonist, [ fl-AIaS]-NKA(4-10) and the selec- 
tive NK 3 receptor agonists, senktide and [MePhe7]-NKB 
had low affinities for stimulating pepsinogen secretion and 
changes in [Ca2+] i and this low affinity interaction could 
be accounted for by their interaction with only the NK~ 
receptors. 
NK~ receptors are reported to be functionally coupled 
to phospholipase C via G proteins in cloned NK 1 receptors 
expressed in Xenopus oocyte [1], as well as in rat parotid 
acinar cells [4], in AR4-2J cells [4,37], and in guinea pig 
pancreatic acinar cells [5,41,42]. The activation of 
phospholipase C leads to breakdown of phosphoinositides, 
cellular calcium mobilization and protein kinase C activa- 
tion [43]. In the present study in chief cells activation of 
the NK~ receptor increased cytosolic alcium, demonstrat- 
ing that it was coupled to phospholipase C. Furthermore, 
the functional importance of this pathway in mediating 
pepsinogen release was supported by the potentiation re- 
suits. Previous studies demonstrate hat two secretagogues 
with similar cellular basis of action do not potentiate each 
other's effect, whereas if they have different mechanisms 
of action, potentiation occurs [26]. Substance P did not 
potentiate the action of cholecystokinin which causes mo- 
bilization of cellular calcium in chief cells [44], whereas 
substance P did potentiate the action of secretin which 
increases cAMP [45]. These results support he conclusion 
that the activation of phospholipase C by the NK ~ receptor 
mediates the pepsinogen release. The activation of the 
NK 1 receptor in the present study showed both similarities 
and differences to activation of NK~ receptors on other 
cells or activation of phospholipase C by other secreta- 
gogues in gastric chief cells. In chief cells, substance P 
was only one-third as efficacious as other phospholipase C 
activating agents uch as CCK-8 or carbachol in stimulat- 
ing changes in [Ca 2+ ]i and pepsinogen secretion. Specifi- 
cally, a maximally effective concentration f substance P 
was 4-fold less efficacious than carbachol in stimulating 
changes in [Ca 2÷ ]i and pepsinogen secretion, respectively. 
Similar to our results, in rabbit stomach glands [17] and 
guinea pig pancreatic acini [5,41,46], substance P was less 
efficacious than CCK-8 in stimulating enzyme secretion. 
However, in canine gastric chief cells, substance P is 
equally efficacious to CCK-8 in stimulating pepsinogen 
secretion [34]. The cellular basis for this difference in 
efficacy is not clear. Differences of receptor number is not 
the only explanation for the differences in secretagogue 
efficacy because guinea pig gastric chief cells possess 
400-times more CCK B receptors than CCK A receptors; 
however, stimulation of the CCK A receptors is 5-times 
more efficacious at activating phospholipase C (i.e., 
changes in [Ca2+] i and [3H]IP) and causing pepsinogen 
release than activation of guinea pig chief cell CCK B 
receptors [47-49]. Whether the difference is due to species 
differences, difference in cell preparation, different signal 
transduction mechanisms, a more rapid desensitization with 
the substance P than the CCK A receptor, or possibly a 
difference in the receptor coupling in different issues, 
remains for further investigation. In recent studies sub- 
stance P was shown to cause calcium oscillations in iso- 
lated guinea pig pancreatic acinar cells in addition to 
increasing cytoplasmic calcium [42]. In the present study, 
no calcium oscillations were seen with substance P over a 
wide concentration range even though low concentrations 
of CCK-8 caused calcium oscillations imilar to that re- 
ported in pancreatic acinar cells. At present it is unclear 
why these two tissues from the same species with NK l 
receptors respond in a different fashion. 
The present study provides ome insight into the rela- 
tionship between NK~ receptor occupation and changes in 
biologic activity with receptor activation. In the present 
study, the dose-range for occupation of the low affinity 
binding sites best correlates with changes in cytosolic 
calcium or pepsinogen release, suggesting that these recep- 
tors mediate changes in biologic activity. These data sug- 
gest that NK l receptors resemble M 3 muscarinic holiner- 
gic receptors on gastric chief cells where, by progressive 
receptor inactivation studies, it was demonstrated that the 
low affinity binding sites of the M 3 cholinergic receptor 
mediate the changes in biologic activity [25]. These results 
are also similar to recent results [53] from studies of the 
action of substance P on changes in [Ca 2÷ ]i, binding of 
125I-BH-substance P and amylase release in guinea pig 
pancreatic acinar cells. Guinea pig pancreatic acinar cells 
possess NK~ receptors [5,41,46] and a recent study [53] 
shows occupation of the low affinity binding sites of the 
NK~ receptor likely mediates substance P-stimulated 
changes in [Ca 2÷ ]i' amylase release and desensitization f 
the pancreatic acinar cell NK 1 receptor. Furthermore, simi- 
lar to the M 3 muscarinic receptor [25], the current study 
suggests that guinea pig chief cells possess spare NK 1 
receptors with the result that submaximal low affinity 
receptor occupation causes maximal changes in [Ca2÷]i, 
and submaximal changes in [Ca2+] i causes maximal 
pepsinogen release. 
The present study demonstrated that binding of radiola- 
beled substance P to the NK~ receptors in gastric chief 
cells was inhibited by agents that activate phospholipase C 
in these cells such as CCK-8 and carbachol or agents that 
activate adenylate cyclase in these cells such as secretin 
[26,44,45]. Gastrin-17-I has been shown to activate phos- 
pholipase C through CCK B receptors on guinea pig chief 
cells [44,49], however its failure to alter binding of ~2sI- 
BH-substance P in the present study was probably due to 
its low efficacy. Activation of CCKB-receptors with gas- 
trin-17-I at low concentrations is only 15% as efficacious 
as activation of CCKA-receptors by CCK-8 [44] and thus, 
the extent of change in ~25I-BH-substance P binding that 
would be expected by CCKB-receptors i within the error 
of the methodology and is too small to be detected. GRP 
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and bombesin, which interact with GRP receptors and 
activate phospholipase C in many tissues [5,50], did not 
alter binding to guinea pig gastric hief cell NK t receptors 
in the present study. This result is consistent with a recent 
study [51] which demonstrates guinea pig chief cells do 
not possess GRP receptors, and neither GRP nor bombesin 
caused activation of phospholipase C or increases in cAMP 
in these cells. The effect on binding to the NK~ receptor of 
activation of both the cAMP and phospholipase C path- 
ways in chief cells was additive, suggesting simultaneous 
activation of both pathways may have an enhancing effect 
on the regulation of NK~ receptors. In general there was 
relatively close agreement between ligand kinetic studies 
and acid-stripping experiments showing 50-60% of the 
radioligand was internalized. Acid-stripping experiments 
demonstrated that the decrease by activation of either the 
cAMP or phospholipase C pathway was due to decreased 
ligand internalization without a direct effect on the surface 
binding parameters of the ligand. These findings have both 
similarities and differences with regulation of binding to 
the NK l receptors in pancreatic acinar cells [19,20], as 
well as regulation of binding to other gastrointestinal 
hormone receptors by various secretagogues [5]. Similar to 
chief cells, substance P binding in guinea pig pancreatic 
acini was inhibited by CCK-8 through the inhibition of 
ligand internalization [19]. However, in pancreatic acinar 
cells only phospholipase C activating agents and not agents 
that activate adenylate cyclase altered substance P binding 
[20]. These differences demonstrates that even though the 
pharmacology of the NKt receptors on guinea pig gastric 
chief cells and pancreatic acini is quite similar in terms of 
relative and absolute affinities for the substance P-related 
peptides, the cellular egulation of substance P interaction 
with the NKt receptors on these two different issues is 
different. Various secretagogues that activate phospho- 
lipase C such as CCK-8 have been reported to inhibit 
binding of somatostatin, endothelin, EGF, IGF-II and in- 
sulin to pancreatic acini [5,52]. With CCK-8 this inhibition 
was due to reduced ligand internalization with the endothe- 
lin, EGF and IGF-II receptors, however, with the somato- 
statin, EGF, or insulin receptor, there were changes in 
receptor affinity or binding capacity causing decreased 
binding [5]. Similar to the NK~ receptors on gastric chief 
cells, binding to the somatostatin receptors and insulin 
receptors was regulated by both phospholipase C and 
adenylate cyclase activating agents, whereas with the en- 
dothelin, EGF and IGF-II receptors, only phospholipase C 
activating agents altered binding [5,52]. The phospholipase 
C activating agents are thought o act through hydrolysis 
of phosphoinositides with formation of calcium mobilizing 
inositol triphosphate and diacylglycerol which activate pro- 
tein kinase C [43]. In our study, both the protein kinase C 
activating agent, TPA and the calcium mobilizing agent, 
A23187 inhibited substance P binding by inhibiting the 
ligand internalization, suggesting both activation of protein 
kinase C and the calcium mobilization pathways regulate 
the internalization. I  other systems uch as in guinea pig 
pancreatic acini, the calcium ionophore A23187 inhibited 
substance P binding similar to our results, however, TPA 
showed no inhibition of the binding [19]. In addition, in 
guinea pig pancreatic acini [19], chelation of extracellular 
calcium increased substance P binding whereas in chief 
cells changes in the concentration f extracellular calcium 
did not alter the amount of surface bound ligand or the 
amount of internalized ligand in chief cells. These differ- 
ences further demonstrate he differences of cellular egu- 
lation of substance P interaction with NK 1 receptors on 
two different tissues within the same species. Activation of 
protein kinase C or calcium mobilization has been reported 
to regulate receptor binding for other gastrointestinal pep- 
tides in other tissues [5] including effects on ligand binding 
to the somatostatin, endothelin, EGF, IGF-II and insulin 
receptor [5]. Calcium mobilization by the calcium 
ionophore also inhibited the binding to the EGF, IGF-II 
and insulin receptor in other tissues, however it demon- 
strated no effect on binding to the somatostatin or endothe- 
lin receptor [5]. Therefore the regulation of NKj receptors 
in guinea pig chief cells by phospholipase C activating 
agents is most similar to their regulation of the EGF 
receptor in pancreatic acini [5]. In both systems, the bind- 
ing to the receptor is decreased by TPA and A23187 and 
mechanism for the inhibition is a reduced ligand internal- 
ization. 
In conclusion, the present study demonstrates that chief 
cells possess a NK 1 subtype of tachykinin receptor, occu- 
pation of the low affinity binding site of this receptor 
causes calcium mobilization and pepsinogen secretion, and 
that binding to this receptor is regulated by agents that 
activate phospholipase C, adenylate cyclase, protein kinase 
C and calcium mobilization. 
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